Pioneering Astaxanthin-Tumor Cell Membrane Nanoparticles for Innovative Targeted Drug Delivery on Melanoma

References

• Dzwierzynski WW. Melanoma risk factors and prevention. Clin Plast Surg. 2021;48(4):543–550. doi:10.1016/j.cps.2021.05.001
   PubMed Web of Science ®Google Scholar
• Ahmed B, Qadir MI, Ghafoor S. Malignant melanoma: skin cancer-diagnosis, prevention, and treatment. Crit Rev Eukary Gene Expres. 2020;30(4):291–297. doi:10.1615/CritRevEukaryotGeneExpr.2020028454
   PubMed Web of Science ®Google Scholar
• Lin YY, Chen CY, Ma DL, Leung CH, Chang CY, Wang HMD. Cell-derived artificial nanovesicle as a drug delivery system for malignant melanoma treatment. Bio Pharmacoth. 2022;147:112586. doi:10.1016/j.biopha.2021.112586
   PubMed Web of Science ®Google Scholar
• Cheng YC, Chang YA, Chen YJ, et al. The roles of extracellular vesicles in malignant melanoma. Cells. 2021;10(10):2740. doi:10.3390/cells10102740
   PubMed Web of Science ®Google Scholar
• Haung HY, Wang YC, Cheng YC, et al. A novel oral astaxanthin nanoemulsion from Haematococcus pluvialis induces apoptosis in lung metastatic melanoma. Oxid Med Cell Longev. 2020;2020:2647670. doi:10.1155/2020/2647670
   PubMed Web of Science ®Google Scholar
• Le QV, Lee J, Lee H, Shim G, Oh YK. Cell membrane-derived vesicles for delivery of therapeutic agents. Acta Pharmaceutica Sinica B. 2021;11(8):2096–2113. doi:10.1016/j.apsb.2021.01.020
   PubMed Web of Science ®Google Scholar
• Cai JX, Liu JH, Wu JY, et al. Hybrid cell membrane-functionalized biomimetic nanoparticles for targeted therapy of osteosarcoma. Int j Nanomed. 2022;2022:837–854. doi:10.2147/IJN.S346685
   Google Scholar
• Prajapat VM, Mahajan S, Paul PG, et al. Nanomedicine: a pragmatic approach for tackling melanoma skin cancer. J Drug Delivery Sci Technol. 2023;104394. doi:10.1016/j.jddst.2023.104394
   Web of Science ®Google Scholar
• Chou HY, Lee C, Pan JL, et al. Enriched astaxanthin extract from Haematococcus pluvialis augments growth factor secretions to increase cell proliferation and induces MMP1 degradation to enhance collagen production in human dermal fibroblasts. Int J Mol Sci. 2016;17(6):955. doi:10.3390/ijms17060955
   PubMed Web of Science ®Google Scholar
• Chen YT, Kao CJ, Huang HY, et al. Astaxanthin reduces MMP expressions, suppresses cancer cell migrations, and triggers apoptotic caspases of in vitro and in vivo models in melanoma. J Funct Foods. 2017;31:20–31. doi:10.1016/j.jff.2017.01.005
   Web of Science ®Google Scholar
• Tseng CC, Lin YJ, Liu W, et al. Metabolic engineering probiotic yeast produces 3S, 3’S-astaxanthin to inhibit B16F10 metastasis. Food Chem Toxicol. 2020;135:110993. doi:10.1016/j.fct.2019.110993
   PubMed Web of Science ®Google Scholar
• Samuel SY, Wang HMD, Huang MY, et al. Safety Assessment of 3S, 3’S astaxanthin derived from metabolically engineered K. marxianus. Antioxidants. 2022;11(11):2288. doi:10.3390/antiox11112288
   Web of Science ®Google Scholar
• Chou HY, Ma DL, Leung CH, Chiu CC, Hour TC, Wang HMD. Purified astaxanthin from Haematococcus pluvialis promotes tissue regeneration by reducing oxidative stress and the secretion of collagen in vitro and in vivo. Oxid Med Cell Longev. 2020;2020:4946902. doi:10.1155/2020/4946902
   PubMed Web of Science ®Google Scholar
• Donoso A, González-Durán J, Muñoz AA, González PA, Agurto-Muñoz C. Therapeutic uses of natural astaxanthin: an evidence-based review focused on human clinical trials. Pharmacol Res. 2021;166:105479 doi:10.1016/j.phrs.2021.105479.
   PubMed Web of Science ®Google Scholar
• Chou HY, Liu LH, Chen CY, et al. Bifunctional mechanisms of autophagy and apoptosis regulations in melanoma from Bacillus subtilis natto fermentation extract. Food and Chemical Toxicology. 2021;150:112020. doi:10.1016/j.fct.2021.112020
   PubMed Web of Science ®Google Scholar
• Huang SJ, Wang TH, Chou YH, et al. Hybrid PEGylated chitosan/PLGA nanoparticles designed as pH-responsive vehicles to promote intracellular drug delivery and cancer chemotherapy. Int J Biol Macromol. 2022;210:565–578. doi:10.1016/j.ijbiomac.2022.04.209
   PubMed Web of Science ®Google Scholar
• Cheng YS, Yen HH, Chang CY, et al. Adipose-derived stem cell-incubated HA-rich sponge matrix implant modulates oxidative stress to enhance VEGF and TGF-β secretions for extracellular matrix reconstruction in vivo. Oxid Med Cell Longev. 2022;2022:1–17. doi:10.1155/2022/9355692
   Web of Science ®Google Scholar
• Lan YH, Lu YS, Wu JY, et al. Cordyceps militaris reduces oxidative stress and regulates immune T cells to inhibit metastatic melanoma invasion. Antioxidants. 2022;11(8):1502. doi:10.3390/antiox11081502
   Web of Science ®Google Scholar
• Fu T, Liang A, Liu Y. Role of P21 in resistance of lung cancer. Zhongguo fei ai za zhi. 2020;23(7):597–602. doi:10.3779/j.issn.1009-3419.2020.101.16
   PubMedGoogle Scholar
• Razavipour SF, Harikumar KB, Slingerland JM. p27 as a transcriptional regulator: new roles in development and cancer. Cancer Res. 2020;80(17):3451–3458. doi:10.1158/0008-5472.CAN-19-3663
   PubMed Web of Science ®Google Scholar
• Li J, Chen CY, Huang JY, et al. Isokotomolide a from Cinnamomum kotoense induce melanoma autophagy and apoptosis in vivo and in vitro. Oxid Med Cell Longev. 2020;2020:3425147. doi:10.1155/2020/3425147
   PubMed Web of Science ®Google Scholar
• Hien HTM, Oanh HT, Quynh QT, et al. Astaxanthin-loaded nanoparticles enhance its cell uptake, antioxidant and hypolipidemic activities in multiple cell lines. J Drug Deliv Sci Technol. 2023;80:104133. doi:10.1016/j.jddst.2022.104133
   Web of Science ®Google Scholar
• Xu C, Ju D, Zhang X. Cell membrane-derived vesicle: a novel vehicle for cancer immunotherapy. Front Immunol. 2022;13:923598. doi:10.3389/fimmu.2022.923598
   PubMed Web of Science ®Google Scholar
• Vaníčková L, Do T, Vejvodová M, et al. Mapping of MeLiM melanoma combining ICP-MS and MALDI-MSI methods. Int J Biol Macromol. 2022;203:583–592. doi:10.1016/j.ijbiomac.2022.01.139
   PubMed Web of Science ®Google Scholar
• Jenkins RW, Fisher DE. Treatment of advanced melanoma in 2020 and beyond. J Invest Dermatol. 2021;141(1):23–31. doi:10.1016/j.jid.2020.03.943
   PubMed Web of Science ®Google Scholar
• Long GV, Schachter J, Arance A, et al. Long-term survival from pembrolizumab (pembro) completion and pembro retreatment: Phase III KEYNOTE-006 in advanced melanoma. Am Soc Clin Oncol. 2020;38:10013. doi:10.1200/JCO.2020.38.15_suppl.10013
   Web of Science ®Google Scholar
• Khalaf K, Hana D, Chou JTT, Singh C, Mackiewicz A, Kaczmarek M. Aspects of the tumor microenvironment involved in immune resistance and drug resistance. Front Immunol. 2021;12(12):656364. doi:10.3389/fimmu.2021.656364
   PubMedGoogle Scholar